Consistent with the concept that TRAIL triggers nonapoptotic signals in normal cells, we have recently demonstrated that systemic TRAIL delivery significantly reduced cardiac fibrosis and apoptosis in a mouse model of diabetic cardiomyopathy [28]. The gene discussed is TNFSF10; the disease is diabetic cardiomyopathy.